Nano-X projected Q2 revenue of about $4.0 million-$4.1 million, up from $3 million a year earlier.
Teleradiology revenue seen at about $2.9 million versus $2.7 million; imaging systems and OEM services about $0.2 million, flat year on year.
AI and software revenue forecast at $1 million versus $0.1 million, mainly tied to consolidating Vaso Healthcare IT (Nanox Health IT).
Cash, cash equivalents, short-term deposits, and long-term restricted deposits expected at about $31.4 million at June 30 versus $60 million at Dec. 31.
Management expects cash and deposits at June 30 will not fund operations for at least one year, raising substantial doubt about going concern.
NNOX•
